Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Praziquantel versus praziquantel plus mefloquine or mefloquine-artesunate for schistosomiasis
ISRCTN00393859Phase 2Completed
- Sponsor
- Swiss Tropical and Public Health Institute
- Start
- Jul 2011
- Modality
- Small Molecules
01
Overview
Phase 2, open-label trial of praziquantel, mefloquine and artesunate in schistosomiasis, schistosomiasis mansoni and schistosomiasis haematobium, sponsored by Swiss Tropical and Public Health Institute. Primary endpoint: Cure rate. Started Jul 2011; status: completed.
02
Drugs
praziquantelmefloquineartesunate
03
Conditions
schistosomiasisschistosomiasis mansonischistosomiasis haematobium
Beyond the preview
Go deeper on ISRCTN00393859.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN00393859.